Skip to content

CorMedix CRMD Pre-Tax Income (Domestic)

Pre-Tax Income (Domestic) at other companies

TFX
TeleflexTFX
-$10.11M+52.9%
Baxter International logo
Baxter InternationalBAX
-$336.25M+10.3%
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's pre-tax income (domestic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's pre-tax income (domestic)?
CorMedix (CRMD) reported pre-tax income (domestic) of $37.5M in Q4 2025.
How has CorMedix's pre-tax income (domestic) changed year-over-year?
CorMedix's pre-tax income (domestic) increased by 886.8% year-over-year, from -$4.77M to $37.5M.
What is the long-term trend for CorMedix's pre-tax income (domestic)?
Over 3 years (2022 to 2025), CorMedix's pre-tax income (domestic) has grown at a 71.1% compound annual growth rate (CAGR), from -$29.97M to $150.02M.
What does pre-tax income (domestic) mean?
The pre-tax earnings generated specifically from domestic business activities, excluding discontinued operations and extraordinary items. This metric isolates the profitability of the company's home-market operations, providing a clear view of core business performance within the primary regulatory and economic environment. It is essential for analyzing domestic operational efficiency and tax planning strategies.